Epigenomics AG (ECX):企業の製品パイプライン分析

◆英語タイトル:Epigenomics AG (ECX) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME7911PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥202,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥303,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi proLung, a validating test for the diagnosis of lung cancer. The company’s molecular diagnostic products are based on its proprietary methylation technology, which is based on biological phenomenon called DNA methylation. The company also offers Epi BiSKit, a pre-analytical kit for the preparation of bisulfite-converted DNA, and HCCBloodTest for the detection of hepatocellular carcinoma (HCC). Epigenomics is headquartered in Berlin, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Epigenomics AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Epigenomics AG Company Overview
Epigenomics AG Company Snapshot
Epigenomics AG Pipeline Products and Ongoing Clinical Trials Overview
Epigenomics AG – Pipeline Analysis Overview
Business Description
Epigenomics AG – Key Facts
Epigenomics AG – Major Products and Services
Epigenomics AG Pipeline Products by Development Stage
Epigenomics AG Ongoing Clinical Trials by Trial Status
Epigenomics AG Pipeline Products Overview
Biomarker PITX2 – Prostate Cancer Prognosis
Biomarker PITX2 – Prostate Cancer Prognosis Product Overview
Blood – Based Lung Cancer Test
Blood – Based Lung Cancer Test Product Overview
Epi proColon 1.0
Epi proColon 1.0 Product Overview
HCCBloodTest
HCCBloodTest Product Overview
HCCBloodTest Clinical Trial
NGS Panel – Bladder Cancer
NGS Panel – Bladder Cancer Product Overview
NGS Panel – Breast Cancer
NGS Panel – Breast Cancer Product Overview
NGS Panel – Colorectal Cancer
NGS Panel – Colorectal Cancer Product Overview
NGS Panel – Lung Cancer
NGS Panel – Lung Cancer Product Overview
NGS Panel – Ovarian Cancer
NGS Panel – Ovarian Cancer Product Overview
NGS Panel – Prostate Cancer
NGS Panel – Prostate Cancer Product Overview
Epigenomics AG – Key Competitors
Epigenomics AG – Key Employees
Epigenomics AG – Key Employee Biographies
Epigenomics AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Epigenomics AG, Recent Developments
Nov 29, 2019: New micro-simulation study in cancer medicine finds Epi proColon provides clinically meaningful reductions in incidence and mortality of colorectal cancer
Nov 19, 2019: Epigenomics reports financial results for the first nine months 2019
Aug 07, 2019: Epigenomics highlights operational achievements and reports financial results for first six months 2019
Jul 24, 2019: Study published in American Health Drug Benefits suggests that non-invasive screening methods, including Epi proColon, could be a cost-effective option to help achieve target U.S. colorectal cancer screening rates
Jul 11, 2019: Epigenomics receives MedTech Outlook’s 2019 top 10 in-vitro diagnostics award
Jun 17, 2019: New clinical data support the utility of Epi proColon blood test for colorectal cancer screening in patients with Lynch Syndrome, the most common hereditary CRC Syndrome
May 19, 2019: New report shows CRC screening rates increased when a medically underserved population is offered Epi proColon Blood Test
May 09, 2019: Epi proColon receives the 2019 Excellence in Molecular Diagnostics Award
May 08, 2019: Epigenomics announces 2019 first quarter financial results
May 03, 2019: CMS accepts Epigenomics’ application for NCD review
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Epigenomics AG Pipeline Products and Ongoing Clinical Trials Overview
Epigenomics AG Pipeline Products by Equipment Type
Epigenomics AG Pipeline Products by Indication
Epigenomics AG Ongoing Clinical Trials by Trial Status
Epigenomics AG, Key Facts
Epigenomics AG, Major Products and Services
Epigenomics AG Number of Pipeline Products by Development Stage
Epigenomics AG Pipeline Products Summary by Development Stage
Epigenomics AG Ongoing Clinical Trials by Trial Status
Epigenomics AG Ongoing Clinical Trials Summary
Biomarker PITX2 - Prostate Cancer Prognosis - Product Status
Biomarker PITX2 - Prostate Cancer Prognosis - Product Description
Blood - Based Lung Cancer Test - Product Status
Blood - Based Lung Cancer Test - Product Description
Epi proColon 1.0 - Product Status
Epi proColon 1.0 - Product Description
HCCBloodTest - Product Status
HCCBloodTest - Product Description
HCCBloodTest - A Multi-center Validation and Development Study of Methylated Cell-free DNA Biomarkers to Aid in the Detection of Hepatocellular Carcinoma in Patients with Cirrhosis
NGS Panel - Bladder Cancer - Product Status
NGS Panel - Bladder Cancer - Product Description
NGS Panel - Breast Cancer - Product Status
NGS Panel - Breast Cancer - Product Description
NGS Panel - Colorectal Cancer - Product Status
NGS Panel - Colorectal Cancer - Product Description
NGS Panel - Lung Cancer - Product Status
NGS Panel - Lung Cancer - Product Description
NGS Panel - Ovarian Cancer - Product Status
NGS Panel - Ovarian Cancer - Product Description
NGS Panel - Prostate Cancer - Product Status
NGS Panel - Prostate Cancer - Product Description
Epigenomics AG, Key Employees
Epigenomics AG, Key Employee Biographies
Epigenomics AG, Subsidiaries
Glossary

★海外企業調査レポート[Epigenomics AG (ECX):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HRG Group, Inc. (HRG)-石油・ガス分野:企業M&A・提携分析
    Summary HRG Group, Inc. (HRG), formerly, Harbinger Group Inc., is a diversified investment holding company, with interests in various businesses such as branded consumer products, which include consumer batteries, residential locksets, faucets, shaving and grooming products, personal care products, …
  • Keg Restaurants Ltd:戦略・SWOT・企業財務分析
    Keg Restaurants Ltd - Strategy, SWOT and Corporate Finance Report Summary Keg Restaurants Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Heidelberger Druckmaschinen AG:企業の戦略・SWOT・財務情報
    Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report Summary Heidelberger Druckmaschinen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SuppreMol GmbH-製薬・医療分野:企業M&A・提携分析
    Summary SuppreMol GmbH (SuppreMol), a subsidiary of Baxalta Inc, is a biopharmaceutical company that develops therapeutics in the areas of autoimmune, chronic inflammatory diseases, and allergies. The company’s lead drug candidate is extensively profiled in in-vitro, ex-vivo and in-vivo experiments. …
  • Biomatrica Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomatrica Inc (Biomatrica) is a developer, manufacturer, and supplier of stability technologies preserve biological materials. The company offers DNA, RNA, proteins, cells, and entire assays for diagnostics, research, forensics, biobanks, and sustainability applications. Its products includ …
  • Gamma Medica Inc:医療機器:M&Aディール及び事業提携情報
    Summary Gamma Medica Inc (Gamma Medica), formerly Gamma Medica Ideas Inc is a medical device company that offers imaging solutions. The company designs, develops and manufactures imaging systems for clinical and pre-clinical applications. It offers lumagem, lumagem mbi workflow, lumagem procedure ov …
  • Proximus plc:企業の戦略・SWOT・財務分析
    Proximus plc - Strategy, SWOT and Corporate Finance Report Summary Proximus plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ContraVir Pharmaceuticals Inc (CTRV):企業の財務・戦略的SWOT分析
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Diagnostics For All Inc:企業の製品パイプライン分析2018
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • Swedbank AB:企業の戦略・SWOT・財務情報
    Swedbank AB - Strategy, SWOT and Corporate Finance Report Summary Swedbank AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ToolGen Inc-製薬・医療分野:企業M&A・提携分析
    Summary ToolGen Inc (ToolGen) is a genome editing company that concentrates on translating the genetic knowledge into transformative products for biomedicine and agriculture. The company creates intellectual property rights for essential tools and technologies for editing the genetic information in …
  • MedDay SA:製薬・医療:M&Aディール及び事業提携情報
    Summary MedDay SA (MedDay) is a biotechnology company that develops drugs for nervous system disorders. The company provides clinical and pharmaceutical development in the field of rare inborn errors of metabolism to treat elucidation of metabolism pathways in the brain. Its pipeline products compri …
  • Novartis Institutes for BioMedical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Institutes for BioMedical Research Inc (NIBR), a subsidiary of Novartis AG is a medical research institute that offers treatment research and development programs. The institute offers clinical research services in areas of immuno-oncology, oncology, neuroscience, cardiovascular and …
  • National Cancer Center Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary National Cancer Center Hospital (NCC) is a healthcare service provider that offers cancer care services. The hospital provides cancer diagnosis and treatment services. It provides services such as examination, treatment, patient care services and co-medical support. NCC provides diagnosis an …
  • Chesswood Group Limited (CHW):企業の財務・戦略的SWOT分析
    Chesswood Group Limited (CHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • RPC Group Plc:企業の戦略的SWOT分析
    RPC Group Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Konica Minolta, Inc.:企業の戦略・SWOT・財務分析
    Konica Minolta, Inc. - Strategy, SWOT and Corporate Finance Report Summary Konica Minolta, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • International Dairy Queen, Inc.:企業の戦略・SWOT・財務情報
    International Dairy Queen, Inc. - Strategy, SWOT and Corporate Finance Report Summary International Dairy Queen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Gulfport Energy Corp (GPOR):企業の財務・戦略的SWOT分析
    Gulfport Energy Corp (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Jackson Electric Membership Corporation:企業の戦略的SWOT分析
    Jackson Electric Membership Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆